Mahesh Kc

7PUBLICATIONS
48CO-AUTHORS
TransgenesisNanomedicineMedical molecular engineering of nucleic acids and proteinsInnate immunityInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2025
Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.

Jiayu Xu, Michelle Chamblee, Fei Jiang

|Aug 06, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.

Cheng Chih Hsu, Michelle Chamblee, Chengjin Ye

|Oct 05, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.

Jiayu Xu, Yuexiu Zhang, Panke Qu

|Mar 07, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.

Mohamed M Shamseldin, Adam Kenney, Ashley Zani

|Jul 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.

Yuexiu Zhang, Mijia Lu, K C Mahesh

|May 19, 2022
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.

Mostafa M Eltobgy, Ashley Zani, Adam D Kenney

Pageof 2